![](/img/cover-not-exists.png)
PCN236 COST-EFFECTIVENESS OF LENALIDOMIDE PLUS LOW DOSE DEXAMETHASONE IN THE CHINESE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA BUT INELIGIBLE FOR STEM CELL TRANSPLANT THERAPY
Lu, J., Gong, Q., Chen, W.Volume:
22
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.04.357
Date:
May, 2019
File:
PDF, 384 KB
2019